MENU

RNA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Atrium Therapeutics (RNA) Ownership - Who owns Atrium Therapeutics?

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies... Show more

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

N/A

Address

10578 Science Center Drive

Phone

+1 619 876-0700

Employees

N/A

Web

N/A

Details

Group

Domestic Stock Funds

Category

Biotechnology

Capitalization

216.56M

P/E Ratio

N/A

Total Cash

267.85M

Projected Growth

N/A

Total Debt

2.68M

Revenue

36.68M

Risk (Beta)

N/A

Dividend Yield

N/A

Total Cash/Share

15.66

Total Debt/Equity

N/A

Revenue/Share

2.14 USD as % of share price

View a ticker or compare two or three

VS

VS

RNA

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for RNA

A.I. Advisor

published General Information

General Information

a company which engages in the research and development of biopharmaceutical products

Industry Biotechnology

Profile

Details

Industry

N/A

Address

10578 Science Center Drive

Phone

+1 619 876-0700

Employees

N/A

Web

N/A